STAT+: Moderna launches early trial of Ebola mRNA vaccine

URL has been copied successfully!

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We’ve got a busy earnings week. Here’s the latest.

The need-to-know this morning

Novo vs. Lilly

The two GLP-1 giants have both reported earnings.

Continue to STAT+ to read the full story…

Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here